In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...
Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...
1d
Military Times on MSNDOD commits $9.8 million to study psychedelics for active-duty troopsDuring one study, physicians at Walter Reed plan to give the psychedelic drug MDMA to active-duty soldiers with mild to ...
1h
News-Medical.Net on MSNUniquely-shaped magnetic nanoparticles offer breakthrough in cancer therapyNew magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ...
Discover the latest breakthroughs in migraine treatment for 2025, including CGRP inhibitors, AI-powered personalized plans, ...
An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...
The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...
INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...
A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...
By replacing the defective gene associated with Dravet syndrome in mice, scientists successfully alleviated symptoms without side effects.
Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results